A greater proportion of BLCA samples with low OBSCN expression exhibited genomically unstable and TCGA type II characteristics, and higher CD8+T effector scores, findings that align with previous TIME analysis (Fig. 5C-D). The gene discussed is CD8A; the disease is bladder transitional cell carcinoma.